.png)
GC Asia
Latest RMB loans/equity news
-
China Reits are not for all
China has taken a long-awaited step towards opening its real estate investment trust (Reit) market, publishing rules for a pilot programme. The regulators are understandably starting small, but the guidelines don’t do enough for companies that need to list Reits the most.
14 May 2020 -
More profits, more ECM deals in 2019 for SSE companies
Most companies listed on the mainboard of Shanghai Stock Exchange (SSE) saw a rise in their 2019 revenues and profits. They also increased their capital raising activity.
06 May 2020 -
China launches public Reit rules after decade-long wait
The China Securities Regulatory Commission and the National Development and Reform Commission have jointly announced a long-awaited pilot programme for real estate investment trusts to promote economic growth. The trial allows the listing of Reits backed by infrastructure projects.
04 May 2020 -
ChiNext reform a step forward but valuation, quality concerns rise
China said this week that it will radically overhaul the ChiNext board, approving a registration-based system for equity fundraising on the Shenzhen Stock Exchange’s start-up focused bourse. This is an important step by the regulator to shift to more market-driven capital markets ─ but plenty of concerns remain. Addison Gong reports.
29 Apr 2020 -
China brings registration-based IPO system to ChiNext
The China Securities Regulatory Commission (CSRC) has kicked off big reforms to the ChiNext board, in a bid to revive its appeal once again to fast growing and high tech companies that have been favouring the Shanghai’s Star market since its launch last year.
28 Apr 2020 -
China’s coronavirus response: capital markets take centre stage
China’s government has won plaudits for its response to the Covid-19 coronavirus. That praise should extend to its capital markets.
14 Apr 2020 -
CSRC raises red flags with Star duo
The China Securities Regulatory Commission (CSRC) has penalised two Star market companies for failing to make sufficient risk disclosures in their IPO documents. The duo were among the first batch of 25 companies to list on the Star board.
14 Apr 2020 -
CSRC mulls faster IPO approvals for Covid-19 affected firms
The China Securities Regulatory Commission (CSRC) is speeding up the approval process for IPOs and follow-ons for companies impacted by the Covid-19 pandemic, GlobalCapital China understands.
09 Apr 2020 -
CSRC gives more clarity to Star board IPO hopefuls
The China Securities Regulatory Commission (CSRC) has shed some light on the kinds of companies that are eligible to list on the Star board, solving part of a problem that has long puzzled potential IPO candidates.
23 Mar 2020 -
Companies plot Star IPO comebacks
Shanghai Titan Scientific, Speechocean and Easton Biopharmaceuticals are all planning to make a second attempt at listing on Shanghai’s Star market.
18 Mar 2020
